Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

AeroLEF studied in phase IIb trial for moderate to severe acute pain

Jan. 30, 2006

Analgesic effects of targeting iNOS in neuropathic and inflammatory pain

Jan. 30, 2006

Novel tachykinin NK1 antagonists disclosed in recent Merck & Co. patent

Jan. 27, 2006

New IP receptor antagonists from Roche show analgesic potential

Jan. 27, 2006

Orphan drug status for Myodur in Duchenne and Becker muscular dystrophies

Jan. 27, 2006

Orphan drug designation for ACR-16 for Huntington's disease

Jan. 27, 2006

NEPP compounds provide neuroprotection via modulation of Keap1/Nrf2 to activate HO-1

Jan. 27, 2006

Posiphen completes first phase I study for Alzheimer's disease progression

Jan. 26, 2006

Eurand inlicenses novel analgesic compounds from Italian universities

Jan. 26, 2006

Promising preclinical results in Duchenne muscular dystrophy at VASTox

Jan. 26, 2006

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...